PLK1 and urinary system neoplasm: Key messages include: Plk1 inhibitors work better in improving the OS, and they are well tolerated, effective and safe in reducing the severity of illness while improving the quality of life, especially in patients with non-specific tumors, respiratory system tumors, musculoskeletal system tumors, and urinary system tumors.